Comparative utilization of the alpha-keto and D- and L-alpha-hydroxy analogs of leucine, isoleucine and valine by chicks and rats. NLM AIDSLINE Important note: Information in this article was accurate in 1983. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Comparative utilization of the alpha-keto and D- and L-alpha-hydroxy analogs of leucine, isoleucine and valine by chicks and rats.

J Nutr. 1982 Oct;112(10):1929-39. Unique Identifier : AIDSLINE MED/83009355
Boebel KP; Baker DH


Abstract: Several experiments were conducted to quantitatively evaluate the growth-promoting capacity of the isomers of the branched-chain amino acids (BCAA) and their alpha-hydroxy and alpha-keto analogs for the chick and rat. Basal chemically defined diets were formulated to be singly deficient in the BCAA under study; analogs therefore were evaluated as sources of supplemental amino acid activity. DL-Isoleucine (DL-Ile), alpha-keto-beta-L-methylvaleric acid (KMV) and the isomers of alpha-hydroxy-beta-methylvaleric acid (HMV) were inferior to an isomolar level of L-Ile and varied considerably in their capacity to support growth of chicks and rats. Efficacy values of the compounds for chicks (C) and rats (R) were: DL-Ile 85% (C), 58% (R); KMV 60% (C), 38% (R); L-HMV 84% (C), 65% (R); DL-HMV 49% (C), 45% (R); and D-HMV -10% (C), -2% (R). The isomers of valine (Val) and alpha-hydroxyisovaleric acid (HIV) had efficacy values in chicks of: DL-Val, 84%; D-Val, 72%; L-HIV, 82%; DL-HIV, 79%; D-HIV, 66%. D-Val had only marginal growth-promoting activity for rats, 16%. All Val analogs had comparable efficacy values for the rat: alpha-ketoisovaleric acid (KIV), 49%; L-HIV, 54%; DL-HIV, 51%; and D-HIV, 46%. DL-Leu and D-Leu, alpha-ketoisocaproic acid (KIC), and L-, DL- and D-alpha-hydroxyisocaproic acid (HIC) were all less efficacious than isomolar amounts of supplemental L-Leu in rats. Efficacy values were: DL-Leu, 78%; D-Leu, 48%; KIC, 56%; L-HIC, 58%; DL-HIC, 55%; and D-HIC, 41%. The BCAA keto analogs were not superior to the L-alpha-hydroxy analogs in growth-promoting capacity, and this is of great interest for the potential use of these nitrogen-free amino acid analogs in nutritional therapy.
Keywords: Animal Chickens Comparative Study Hexanoic Acids/METABOLISM Isoleucine/*ANALOGS & DERIVATIVES/METABOLISM Keto Acids/METABOLISM Leucine/*ANALOGS & DERIVATIVES/METABOLISM Male Pentanoic Acids/METABOLISM Rats Species Specificity Structure-Activity Relationship Valerates/METABOLISM Valine/*ANALOGS & DERIVATIVES/METABOLISM JOURNAL ARTICLE

KWDanimalchickenscomparativestudyhexanoicacids/metabolismisoleucine/KWDanalogs&derivatives/metabolismketoacids/metabolismleucine/KWDanalogs&derivatives/metabolismmalepentanoicacids/metabolismratsspeciesspecificitystructure-activityrelationshipvalerates/metabolismvaline/KWDanalogs&derivatives/metabolismjournalarticle
830130
M8310018


Copyright © 1983 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1983. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1983. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .